Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (56.201)

91

Multivalent Rhamnose-Modified EGFR-Targeting Nanobody Gains Enhanced Innate Fc Effector Immunity and Overcomes Cetuximab Resistance via Recruitment of Endogenous Antibodies

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

von Li, Y. | Lin, H. | Hong, H. | +5

92

Population Pharmacokinetics of Nirsevimab in Preterm and Term Infants

enthalten in: Journal of clinical pharmacology | 2024

von Clegg, L. | Freshwater, E. | Leach, A. | +2

93

Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma : final analysis of the randomized phase 2 FIGHT trial

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2024

von Wainberg, Z. | Kang, Y. | Lee, K. | +15

94

Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Peters, S. | Angevin, E. | Alonso-Gordoa, T. | +22

95

Biomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with Asthma

enthalten in: American journal of respiratory and critical care medicine | 2024

von Pavord, I. | De Prado Gómez, L. | Brusselle, G. | +15

96

Baseline eosinophil level may be a predictive indicator for the effectiveness of dupilumab in patients with prurigo nodularis : A single-center, real-world prospective study

enthalten in: Journal of the American Academy of Dermatology | 2024

von Yi, X. | Cao, Q. | Peng, C. | +2

97

Vitreous Opacity Following Intravitreal Brolucizumab Injection : A Case Series Review

enthalten in: Korean journal of ophthalmology : KJO | 2024

von Lee, K. | Lee, S. | Lee, M.

98

Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response

enthalten in: Journal of neuro-oncology | 2024

von Bobholz, S. | Hoefs, A. | Hamburger, J. | +9

UpdateOf: Res Sq. 2024 Jan 08;:. - PMID 38260400

99

Efficacy and safety of trastuzumab deruxtecan in treating human epidermal growth factor receptor 2-low/positive advanced breast cancer:A meta-analysis of randomized controlled trials

enthalten in: Critical reviews in oncology/hematology | 2024

von Ma, R. | Shi, Y. | Yan, R. | +3

100

Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy

enthalten in: International journal of cancer | 2024

von Masetti, M. | Al-Batran, S. | Goetze, T. | +14